4Chen L,Yang B.Immunohistochemical analysis of p16,p53,and Ki-67 expression in uterine smooth mnscle tumors[J].Int J Gynecol Pathol,2008,27(3):326-332.
5Giuntoli RL,Garrett-Mayer E,Bristow RE,et al.Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma[J].Gynecol Oncol,2007,106(1):82-88.
6Hock Y L,Goswami P,Rollason TP.Mitotically active haenorrhagic cellular(apoplectic) Leiomyoma[J].Eur J Gynaecol Oncol,2000,21(1):28-29.
7Norris HJ,Hilliard GD,Irey NS.Hemorrhagic cellular leiomyomas (apoplectic leiomyoma) of the uterus associated with pregnaney and oral contraceptives[J].Int J Gynecol Pathol,1998,7(3):212-223.
8Buttram VC Jr,Reiter RC.Uterine leiomyomata:etiology,symptomatology and management[J].Fertil Steril,1981,36(4):433-445.
9Zhai YL,Kohaya Shi Y,Mori A,et al.Expression of steroid receptors,ki-67 and p53 in uterine leiomyosarcoma[J].Int J Gynecol Pathol,1999,18(1):20-28.
10Yvette La,Coursiere D,Chin HG.Pedunculated atypical leiomyoma presenting as a hemoperitoneum[J].J Gynecol Surg,2005,21(1):21-24.
